NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 82 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41 | -60.6% | 38,861 | -3.8% | 0.00% | – |
| Q2 2023 | $104 | -41.9% | 40,390 | -8.4% | 0.00% | – |
| Q1 2023 | $179 | -48.9% | 44,077 | -36.9% | 0.00% | – |
| Q4 2022 | $350 | -99.9% | 69,904 | +59.3% | 0.00% | -100.0% |
| Q3 2022 | $575,000 | +76.4% | 43,895 | +72.6% | 0.00% | – |
| Q2 2022 | $326,000 | +10.5% | 25,436 | +31.3% | 0.00% | – |
| Q1 2022 | $295,000 | -85.1% | 19,371 | -82.6% | 0.00% | – |
| Q4 2021 | $1,974,000 | +190.7% | 111,520 | +245.7% | 0.00% | – |
| Q3 2021 | $679,000 | +452.0% | 32,261 | +420.2% | 0.00% | – |
| Q2 2021 | $123,000 | -84.1% | 6,202 | -76.7% | 0.00% | – |
| Q1 2021 | $773,000 | +57.1% | 26,569 | +63.6% | 0.00% | – |
| Q4 2020 | $492,000 | +21.8% | 16,238 | -36.1% | 0.00% | – |
| Q3 2020 | $404,000 | -10.2% | 25,396 | +11.2% | 0.00% | – |
| Q2 2020 | $450,000 | +63.0% | 22,830 | +2.0% | 0.00% | – |
| Q1 2020 | $276,000 | -65.5% | 22,381 | -48.3% | 0.00% | – |
| Q4 2019 | $800,000 | +99.5% | 43,314 | +49.8% | 0.00% | – |
| Q3 2019 | $401,000 | -6.3% | 28,916 | -1.3% | 0.00% | – |
| Q2 2019 | $428,000 | – | 29,293 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,766,666 | $59,928,000 | 49.90% |
| Greenspring Associates, LLC | 1,573,357 | $25,032,000 | 38.95% |
| Svennilson Peter | 18,017,932 | $286,665,000 | 23.39% |
| Aquilo Capital Management, LLC | 1,018,334 | $16,202,000 | 1.72% |
| Jasper Ridge Partners, L.P. | 308,750 | $4,912,000 | 0.28% |
| Samsara BioCapital, LLC | 36,451 | $580,000 | 0.16% |
| Rock Springs Capital Management LP | 360,454 | $5,735,000 | 0.15% |
| Point72 Asset Management, L.P. | 1,611,850 | $25,645,000 | 0.13% |
| Virtus ETF Advisers LLC | 14,880 | $237,000 | 0.12% |
| WELD CAPITAL MANAGEMENT LLC | 15,238 | $242,000 | 0.10% |